DBD
NYSE TechnologyDiebold Nixdorf Incorporated Common stock
Software - Application
Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. It operates through two segments, Banking and Retail. The company offers automated teller machines, cash recyclers, dispensers, teller automation tools, and kiosk technologies. The Banking segment manufactures and sells branch automation solutions, including DN Series recyclers, ATMs, cash recycling technology, and the DN Teller Cash Recycler and Dual Tower Recycler, as well as provides multi-vendor service capabilities and DN Vynamic software for enhanced connectivity and analytics. It offers professional services such as systems integration, customization, project management, and consulting for integrated solutions. The Retail segment offers modular and integrated electronic point-of-sale (EPOS) systems, self-checkout solutions like DN Series EASY ONE and EASY MAX Kiosk, BEETLE POS systems, and a broad range of peripherals, including printers, scales, and mobile scanners. It also provides the DN Vynamic Retail Platform, which includes industry-specific solutions for fuel, convenience, specialty, fashion, and grocery; and platforms for digital receipts, rewards, data analysis, and compliance, as well as offers maintenance, support, global integration, remote device monitoring, and advisory services utilizing AI for predictive diagnostics and operational efficiencies. In addition, the company provides integrated core operations supporting security and efficient cash management, with offerings including installation, maintenance, managed services, automation, and data intelligence via the Allconnect data engine. The company was formerly known as Diebold, Incorporated and changed its name to Diebold Nixdorf, Incorporated in December 2016. Diebold Nixdorf, Incorporated was founded in 1859 and is headquartered in North Canton, Ohio.
๐ Market Data
| Price | $77.86 |
|---|---|
| Volume | 405,231 |
| Market Cap | 2.71B |
| Beta | 1.480 |
| RSI (14-Day) | 32.8 |
| 200-Day MA | $67.25 |
| 50-Day MA | $79.36 |
| 52-Week High | $89.05 |
| 52-Week Low | $43.61 |
| P/E Ratio | 26.85 |
| Forward P/E | 11.18 |
| Price / Book | 2.67 |
๐ฏ Investment Strategy Scores
DBD scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (91/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ Over-Hyped (7/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find DBD in your text
Paste any article, transcript, or post โ the tool will extract DBD and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.